Validation of the generalized anxiety disorder screener (GAD-7) in Cypriot pregnant and postpartum women.
Anxiety
GAD-7
Perinatal anxiety
Postpartum
Pregnancy
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
15 Nov 2022
15 Nov 2022
Historique:
received:
09
05
2022
accepted:
18
10
2022
entrez:
15
11
2022
pubmed:
16
11
2022
medline:
19
11
2022
Statut:
epublish
Résumé
Anxiety is increasingly acknowledged as a common mental health issue during the perinatal period. Its prevalence as well as the associated adverse effects constitute screening imperative. This study evaluates the psychometric properties and underlying factor structures of a Greek version of GAD-7 among pregnant and postpartum women (up to 6 months) in Cyprus. This study was conducted from June to December 2020. A total of 457 Cypriot women in the perinatal period (222 pregnant and 235 postpartum) were surveyed. The assessment included anxiety (GAD-7) and depression (EPDS), and psychosocial factors related with anxiety. The internal consistency and factor structure of GAD-7 were evaluated using reliability coefficients, Cronbach's Alpha and McDonald's Omega, and factor analysis, both Exploratory as well as Confirmatory. GAD-7 demonstrated good internal consistency (α = 0.907; Ω = 0.909). Horn's parallel analysis indicated a single factor as the most appropriate. CFA using the standard ML method indicated a good model fit, χ GAD-7 is a valid and reliable measure and healthcare professionals should utilize GAD-7 as a standard instrument for the screening of anxiety symptoms in pregnant and postpartum Greek Cypriot women.
Sections du résumé
BACKGROUND
BACKGROUND
Anxiety is increasingly acknowledged as a common mental health issue during the perinatal period. Its prevalence as well as the associated adverse effects constitute screening imperative. This study evaluates the psychometric properties and underlying factor structures of a Greek version of GAD-7 among pregnant and postpartum women (up to 6 months) in Cyprus.
METHODS
METHODS
This study was conducted from June to December 2020. A total of 457 Cypriot women in the perinatal period (222 pregnant and 235 postpartum) were surveyed. The assessment included anxiety (GAD-7) and depression (EPDS), and psychosocial factors related with anxiety. The internal consistency and factor structure of GAD-7 were evaluated using reliability coefficients, Cronbach's Alpha and McDonald's Omega, and factor analysis, both Exploratory as well as Confirmatory.
RESULTS
RESULTS
GAD-7 demonstrated good internal consistency (α = 0.907; Ω = 0.909). Horn's parallel analysis indicated a single factor as the most appropriate. CFA using the standard ML method indicated a good model fit, χ
CONCLUSIONS
CONCLUSIONS
GAD-7 is a valid and reliable measure and healthcare professionals should utilize GAD-7 as a standard instrument for the screening of anxiety symptoms in pregnant and postpartum Greek Cypriot women.
Identifiants
pubmed: 36380278
doi: 10.1186/s12884-022-05127-7
pii: 10.1186/s12884-022-05127-7
pmc: PMC9665014
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
841Subventions
Organisme : NCI NIH HHS
ID : R01 CA018138
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA018138
Pays : United States
Informations de copyright
© 2022. The Author(s).
Références
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Behav Res Methods. 2016 Sep;48(3):936-49
pubmed: 26174714
J Affect Disord. 2019 May 1;250:363-370
pubmed: 30877859
J Clin Psychiatry. 2018 Sep 4;79(5):
pubmed: 30192449
Psychiatry Res. 2021 Jun;300:113912
pubmed: 33836471
BMJ Open. 2018 Sep 5;8(9):e023766
pubmed: 30185582
Infant Behav Dev. 2017 Nov;49:120-128
pubmed: 28886563
Arch Womens Ment Health. 2018 Jun;21(3):287-297
pubmed: 29046965
J Affect Disord. 2019 Aug 1;255:27-40
pubmed: 31129461
Obstet Gynecol. 2015 May;125(5):1268-1271
pubmed: 25932866
J Clin Psychiatry. 2019 Jul 23;80(4):
pubmed: 31347796
J Affect Disord. 2014 Apr;159:103-10
pubmed: 24679397
Arch Womens Ment Health. 2019 Oct;22(5):543-556
pubmed: 30523416
Gen Hosp Psychiatry. 2004 Jul-Aug;26(4):289-95
pubmed: 15234824
PLoS One. 2015 Apr 27;10(4):e0125096
pubmed: 25915929
J Affect Disord. 2021 Mar 1;282:98-103
pubmed: 33401129
Br J Psychiatry. 2017 May;210(5):315-323
pubmed: 28302701
BJPsych Open. 2019 Jan;5(1):e5
pubmed: 30762504
Can J Psychiatry. 2014 Aug;59(8):434-40
pubmed: 25161068
J Pers Assess. 2005 Aug;85(1):17-32
pubmed: 16083381
J Consult Clin Psychol. 1987 Aug;55(4):584-594
pubmed: 3624616
J Obstet Gynecol Neonatal Nurs. 2017 Mar - Apr;46(2):272-281
pubmed: 28190757
Front Psychol. 2016 May 26;7:769
pubmed: 27303333
J Clin Med. 2021 May 29;10(11):
pubmed: 34072357
Arch Womens Ment Health. 2020 Dec;23(6):741-748
pubmed: 33263142
Psicothema. 2021 Feb;33(1):164-170
pubmed: 33453750
Infant Behav Dev. 2018 May;51:24-32
pubmed: 29544195
J Affect Disord. 2014 Dec;169:203-11
pubmed: 25212996
BMC Public Health. 2021 Feb 17;21(1):368
pubmed: 33596889